BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37262995)

  • 1. Sensitization of colon cancer cells to cisplatin by Fbxw7 via negative regulation of the Nox1-mTOR pathway.
    Huang G; Long K
    Pathol Res Pract; 2023 Jul; 247():154479. PubMed ID: 37262995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuating glucose metabolism by
    Wang HP; Chen WJ; Shen JM; Ye T; Xie HW
    Ann Transl Med; 2021 May; 9(10):886. PubMed ID: 34164520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
    Lu H; Yao B; Wen X; Jia B
    BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin Suppresses Glycolysis and Increases Cisplatin Chemosensitivity in Oral Squamous Cell Carcinoma
    Cai Y; Gao Q; Meng JH; Chen L
    Nutr Cancer; 2023; 75(3):1028-1037. PubMed ID: 36718661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
    Pekarčíková L; Knopfová L; Beneš P; Šmarda J
    Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑223‑induced inhibition of the
    Liu Z; Ma T; Duan J; Liu X; Liu L
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.
    Ding J; Zhao Z; Song J; Luo B; Huang L
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):597-604. PubMed ID: 29701752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOX1 mediates chemoresistance via HIF1α/MDR1 pathway in gallbladder cancer.
    Zhan M; Wang H; Chen T; Chen W; Yang L; He M; Xu S; Wang J
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):79-85. PubMed ID: 26545779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.
    Saber MM; Al-Mahallawi AM; Nassar NN; Stork B; Shouman SA
    BMC Cancer; 2018 Aug; 18(1):822. PubMed ID: 30111296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
    Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
    Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer.
    He D; Ma Z; Fang C; Ding J; Yang W; Chen P; Huang L; Wang C; Yu Y; Yang L; Li Y; Zhou Z
    Cancer Lett; 2019 Jul; 454():53-65. PubMed ID: 30981757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.
    Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X
    Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X; Jin W; Jia H; Yan J; Zhang G
    J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
    Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway.
    Wang HP; Wang X; Gong LF; Chen WJ; Hao Z; Feng SW; Wu YB; Ye T; Cai YK
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4474-4481. PubMed ID: 27874952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
    Kearns CA; Ravanelli AM; Cooper K; Appel B
    J Neurosci; 2015 Nov; 35(44):14861-71. PubMed ID: 26538655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.